Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis (MS) based on its pleiotropic effects, but continued progression of the field requires better future designs and methodologies.
Objectives:
This paper outlines the work of the ‘Study design and methodology’ group of the MoXFo (moving exercise research forward) initiative, and addresses critical aspects and future directions when defining the research question of interest, and subsequently, designing the study and exercise intervention in MS patients.
Methods:
The work is based on the formation of an international expert panel formed within the MoXFo initiative. We provide a structured and concise synthesis of exercise-specific MS research challenges and considerations when designing randomized controlled trials (RCTs).
Results:
Challenges and considerations are presented using the Patient population, Intervention, Comparator, Outcomes, Timing, Setting (PICOTS) framework, thereby forming a new and specific MS exercise PICOTS framework.
Conclusion:
We propose that researchers should carefully consider and align all elements of this MS exercise PICOTS framework when developing future research questions and study designs, ultimately improving the quality of new exercise studies in people with MS.
DalgasULangeskov-ChristensenMStenagerE, et al. Exercise as medicine in multiple sclerosis-time for a paradigm shift: Preventive, symptomatic, and disease-modifying aspects and perspectives. Curr Neurol Neurosci Rep2019; 19(11): 88.
2.
SchlagheckMLJoistenNWalzikD, et al. Systematic review of exercise studies in persons with multiple sclerosis: Exploring the quality of interventions according to the principles of exercise training. Neurol Ther2021; 10(2): 585–607.
3.
das NairRde GrootVFreemanJ. Beyond current research practice: Methodological considerations in MS rehabilitation research (is designing the perfect rehabilitation trial the Holy Grail or a Gordian knot?). Mult Scler2019; 25(10): 1337–1347.
4.
BothwellLEGreeneJAPodolskySH, et al. Assessing the gold standard–Lessons from the history of RCTs. N Engl J Med2016; 374(22): 2175–2181.
5.
BoutronIAltmanDGMoherD, et al. CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med2017; 167(1): 40–47.
6.
SladeSCDionneCEUnderwoodM, et al. Consensus on exercise reporting template (CERT): Modified Delphi study. Phys Ther2016; 96(10): 1514–1524.
7.
HoffmannTCGlasziouPPBoutronI, et al. Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide. BMJ2014; 348: g1687.
8.
HeckstedenAFaudeOMeyerT, et al. How to construct, conduct and analyze an exercise training study?Front Physiol2018; 9: 1007.
9.
NayakBK. Understanding the relevance of sample size calculation. Indian J Ophthalmol2010; 58(6): 469–470.
10.
RiemenschneiderMHvidLGRinggaardS, et al. Study protocol: Randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES). BMJ Open2021; 11(1): e043699.
11.
LaiBCederbergKVanderbomKA, et al. Characteristics of adults with neurologic disability recruited for exercise trials: A secondary analysis. Adapt Phys Activ Q2018; 35(4): 476–497.
12.
EdwardsTPiluttiLA. The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions. Mult Scler Relat Disord2017; 16: 31–39.
13.
MagyariMSorensenPS. The changing course of multiple sclerosis: Rising incidence, change in geographic distribution, disease course, and prognosis. Curr Opin Neurol2019; 32(3): 320–326.
14.
HortonSMacDonaldDJEricksonK. MS, exercise, and the potential for older adults. Eur Rev Aging Phys Act2010; 7(1): 49–57.
15.
JakimovskiDEckertSPZivadinovR, et al. Considering patient age when treating multiple sclerosis across the adult lifespan. Expert Rev Neurother2021; 21(3): 353–364.
16.
HvidLGFeysPBaertI, et al. Accelerated trajectories of walking capacity across the adult life span in persons with multiple sclerosis: An underrecognized challenge. Neurorehabil Neural Repair2020; 34(4): 360–369.
17.
RiemenschneiderMHvidLGStenagerE, et al. Is there an overlooked ‘window of opportunity’ in MS exercise therapy? Perspectives for early MS rehabilitation. Mult Scler2018; 24(7): 886–894.
18.
HoffmanJ. Physiological aspects of sport training and performance. Champaign, IL: Human Kinetics, 2014.
19.
KalbRBrownTRCooteS, et al. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler2020; 26(12): 1459–1469.
20.
ColucciEClarkALangCE, et al. A rule-based, dose-finding design for use in stroke rehabilitation research: Methodological development. Physiotherapy2017; 103(4): 414–422.
21.
LevackWMMartinRAGrahamFP, et al. Compared to what? An analysis of the management of control groups in Cochrane reviews in neurorehabilitation. Eur J Phys Rehabil Med2019; 55(3): 353–363.
22.
RasovaKFreemanJCattaneoD, et al. Content and delivery of physical therapy in multiple sclerosis across Europe: A survey. Int J Environ Res Public Health2020; 17(3): 886.
23.
Langeskov-ChristensenMGrondahl HvidLNygaardMKE, et al. Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis. Neurology2021; 96: e203–e213.
24.
HeinrichIRosenthalFPatraS, et al. Arm ergometry to improve mobility in progressive multiple Sclerosis (AMBOS) – Results of a pilot randomized controlled trial. Front Neurol2021; 12: 644533.
25.
ZimmerPBlochWSchenkA, et al. High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial. Mult Scler2018; 24(12): 1635–1644.
26.
WensIDalgasUVandenabeeleF, et al. High intensity aerobic and resistance exercise can improve glucose tolerance in persons with multiple sclerosis: A randomized controlled trial. Am J Phys Med Rehabil2017; 96(3): 161–166.
27.
HahnS. Understanding noninferiority trials. Korean J Pediatr2012; 55(11): 403–407.
28.
MauriLD’AgostinoRB. Challenges in the design and interpretation of noninferiority trials. N Engl J Med2017; 377(14): 1357–1367.
29.
SchulzKFAltmanDGMoherD, et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ2010; 340: c332.
30.
HarringtonDD’AgostinoRBSrGatsonisC, et al. New guidelines for statistical reporting in the journal. N Engl J Med2019; 381(3): 285–286.
31.
AmrheinVGreenlandSMcShaneB. Scientists rise up against statistical significance. Nature2019; 567(7748): 305–307.
32.
PaulLCooteSCrosbieJ, et al. Core outcome measures for exercise studies in people with multiple sclerosis: Recommendations from a multidisciplinary consensus meeting. Mult Scler2014; 20(12): 1641–1650.
33.
RamariCAwadiaZBansiJ, et al. The MoxFo initiative – Outcomes: Outcome measures in studies of exercise training in multiple sclerosis; scoping review of reviews and classification according to the ICF Framework. Mult Scler J.
34.
FeysPBibbyBRombergA, et al. Within-day variability on short and long walking tests in persons with multiple sclerosis. J Neurol Sci2014; 338(1–2): 183–187.
35.
DennettRMadsenLTConnollyL, et al. Adherence and drop-out in randomized controlled trials of exercise interventions in people with multiple sclerosis: A systematic review and meta-analyses. Mult Scler Relat Disord2020; 43: 102169.
36.
RooneySAlbalawiHPaulL. Exercise in the management of multiple sclerosis relapses: Current evidence and future perspectives. Neurodegener Dis Manag2020; 10(2): 103–115.
37.
MazzettiSAKraemerWJVolekJS, et al. The influence of direct supervision of resistance training on strength performance. Med Sci Sports Exerc2000; 32(6): 1175–1184.
38.
SnookEMMotlRW. Effect of exercise training on walking mobility in multiple sclerosis: A meta-analysis. Neurorehabil Neural Repair2009; 23(2): 108–116.
39.
TallnerAStreberRHentschkeC, et al. Internet-supported physical exercise training for persons with multiple sclerosis-A randomised, controlled study. Int J Mol Sci2016; 17(10): 1667.
40.
MotlRWBackusDNealWN, et al. Rationale and design of the STEP for MS trial: Comparative effectiveness of supervised versus telerehabilitation exercise programs for multiple sclerosis. Contemp Clin Trials2019; 81: 110–122.
41.
LearmonthYCChanZCorreiaH, et al. Exercise participation and promotion in the multiple sclerosis community; perspectives across varying socio-ecological levels. Disabil Rehabil2021; 43: 3623–3638.
42.
Latchem-HastingsJRandellEButtonK, et al. Lifestyle, exercise and activity package for people living with progressive multiple sclerosis (LEAP-MS): Protocol for a single-arm feasibility study. Pilot Feasibility Stud2021; 7(1): 111.
43.
ChungKCSongJWWRIST Study Group. A guide to organizing a multicenter clinical trial. Plast Reconstr Surg2010; 126(2): 515–523.
44.
CoupeNMathiesonA. Patient and public involvement in doctoral research: Impact, resources and recommendations. Health Expect2020; 23(1): 125–136.
45.
ChanAWTetzlaffJMAltmanDG, et al. SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Ann Intern Med2013; 158(3): 200–207.
46.
GambleCKrishanAStockenD, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA2017; 318(23): 2337–2343.
